佐力药业2024年度拟派4.15亿元红包

Core Viewpoint - Zhaoli Pharmaceutical announced a cash dividend plan for the year 2024, proposing a distribution of 6 yuan per 10 shares (including tax), totaling approximately 415 million yuan, which represents 81.82% of the net profit and a dividend yield of 4.23% based on the average trading price for the year [2][3]. Company Summary - Zhaoli Pharmaceutical's revenue for 2024 reached 2.578 billion yuan, marking a year-on-year increase of 32.71%, while net profit was 508 million yuan, also up by 32.60%. The basic earnings per share stood at 0.73 yuan, with a weighted average return on equity of 18.55% [2]. - The company has distributed dividends 14 times since its listing, with the latest proposal being the highest payout per share to date [2][3]. Industry Summary - In the pharmaceutical and biotechnology sector, 223 companies have announced their dividend plans for 2024. WuXi AppTec leads with a total cash distribution of 7.692 billion yuan, followed by Yunnan Baiyao and Heng Rui Medicine with distributions of 2.114 billion yuan and 1.275 billion yuan, respectively [3]. - Zhaoli Pharmaceutical ranks among the top companies in terms of cash distribution, with a payout of 415 million yuan, which is 81.82% of its net profit, placing it favorably within the industry [4].